Synthesis of α‐Aryl and α‐Heteroaryl 4‐Silyloxy Piperidines via a One‐Pot Negishi Cross‐Coupling Approach

The direct α-arylation of a protected 4-hydroxy piperidine via a one-pot Negishi cross-coupling reaction is described. The methodology uses a single solvent, toluene, for the lithiation/transmetallation/Negishi sequence and 20 examples are presented. Of note, the high-yielding cross-coupling of a range of pharmaceutically relevant heteroaryl bromides is reported. The reactions show high levels of 2,4-cis-diastereoselectivity and further functionalizations are also described. Piperidine is the most common nitrogen heterocycle in approved drugs and our approach delivers such heterocycles via a direct diastereoselective α-functionalization of 4-substituted N-Boc piperidines; as such, the approach is ready to be utilized in the pharmaceutical industry.

Authors

Institutions

Publication Details

Journal
Chemistry - A European Journal
Published
2025-04-16
DOI
https://doi.org/10.1002/chem.202500863
Citations
2
Primary Topic
Catalytic Cross-Coupling Reactions
Type
article
Field-Weighted Citation Impact
1.87
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Synthesis of α‐Aryl and α‐Heteroaryl 4‐Silyloxy Piperidines via a One‐Pot Negishi Cross‐Coupling Approach

Matthew T. Gill, John Humphrey, James D. Firth, Andres R. Gomez-Angel et al.
2 citations
Chemistry - A European Journal
Catalytic Cross-Coupling Reactions
1.87
article

Synthesis of α‐Aryl and α‐Heteroaryl 4‐Silyloxy Piperidines via a One‐Pot Negishi Cross‐Coupling Approach

Matthew T. Gill, John Humphrey, James D. Firth, Andres R. Gomez-Angel, Peter O’Brien, Ricardo Lira, David C. Blakemore, Lucy A. Tomczyk
article en
2 citations

Abstract

The direct α-arylation of a protected 4-hydroxy piperidine via a one-pot Negishi cross-coupling reaction is described. The methodology uses a single solvent, toluene, for the lithiation/transmetallation/Negishi sequence and 20 examples are presented. Of note, the high-yielding cross-coupling of a range of pharmaceutically relevant heteroaryl bromides is reported. The reactions show high levels of 2,4-cis-diastereoselectivity and further functionalizations are also described. Piperidine is the most common nitrogen heterocycle in approved drugs and our approach delivers such heterocycles via a direct diastereoselective α-functionalization of 4-substituted N-Boc piperidines; as such, the approach is ready to be utilized in the pharmaceutical industry.

Chemistry - A European JournalVol. 31(31)
Pfizer (United States) (US), Pfizer (United Kingdom) (GB), University of York (GB)
Industry, innovation and infrastructure
Openalex Percentile: Top 16%
Catalytic Cross-Coupling Reactions
1.87
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Synthesis of α‐Aryl and α‐Heteroaryl 4‐Silyloxy Piperidines via a One‐Pot Negishi Cross‐Coupling Approach — Matthew T. Gill, John Humphrey, et al. · Chemistry - A European Journal (2025) | TGRS Research Map | TGRS